Ana Aparicio, MD of MD Anderson Cancer Center discusses her opinion on whether or not BRCA1 and BRCA2 genetic testing should be added to guidelines for prostate cancer treatment at the 2017 Genitourinary Cancers Symposium (Annual Meeting GU) in Orlando, Florida.
Should BRCA1 and BRCA2 Genetic Testing Be Added to Guidelines for Prostate Cancer
